drugset / Trial / NCT02702700
Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This clinical study aims to explore intrapleural low-dose Visudyne®-mediated photodynamic therapy (photo-induction) as a pathway to promote the uptake of systemically administered Lipoplatin™ in pleural malignancies of patients undergoing video-assisted talcage for their malignant pleural effusions. Photo-induction is expected to overcome the chemo-resistance of pleural malignancies for cisplatin-based chemotherapeutics and thereby improve local tumor control.
Timeline
- Start
- 2016-01
- Primary completion
- 2018-08-28
- Completion
- 2018-08-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 200 mg/m2 | Intravenous |
| Subject | Verteporfin | Other / unclassified | 3 mg/m2 | Intravenous |